An Incomplete List of COVID-19 Quackery
Possibly the only thing spreading faster than COVID-19 is the pseudoscience about COVID-19.
Send us a link
Opendata.ch - 2020 Forum
The Opendata.ch 2020 Forum will explore New Data Narratives, diving in deep collaborative work, and aiming high!
Publishers Invest in Preprints
Major scholarly publishers have invested substantially in preprints in recent years, integrating preprint deposit into manuscript submission workflows.
#ECRWednesday Webinar: Reforming Academic Conferences
Join this month's webinar to hear what could be done to reform the conference experience for both organisers and participants.
Swissuniversities and Elsevier Adopt a Pilot Agreement Combining Reading and Publishing
Swissuniversities and Elsevier Adopt a Pilot Agreement Combining Reading and Publishing
Swissuniversities has adopted a new transformative pilot agreement with Elsevier for research access and Open Access publishing in Switzerland.
Reasons to Worry Less About the Explosion of Preprints - Absolutely Maybe
Data Sharing in the Current Crisis
Data sharing and COVID-19- the pandemic is changing the way scientists work and talk to each other. The Early Career Researchers advisory board at Wellcome Open Research discuss how COVID-19 is changing science.
The Rogue Experimenters
Community labs want to make everything from insulin to prostheses. Will traditional scientists accept their efforts?
Cambridge Lectures to Be Online-only in 2020-21
There will be no face-to-face lectures in the next academic year due to coronavirus, the university says.
Dutch Research Institutions and Elsevier Initiate World's First National Open Science Partnership
Dutch Research Institutions and Elsevier Initiate World's First National Open Science Partnership
VSNU, NFU, NWO and Elsevier have agreed publishing, reading and open science services to support Dutch research and innovation ambitions.
Vaccine Experts Say Moderna's Covid-19 Data Leave Big Questions
While Moderna blitzed the media, it revealed very little information - and most of what it did disclose were words, not data.
COAlition S Announces Price Transparency Requirements | Plan S
From July 2022 only publishers who adhere to the newly approved Plan S price transparency frameworks will be eligible to access funds from cOAlition S members.
Scientists Are Drowning in COVID-19 Papers. Can New Tools Keep Them Afloat?
Scientists Are Drowning in COVID-19 Papers. Can New Tools Keep Them Afloat?
The hunt is on for better ways to collect and search pandemic studies
Professor Dame Ottoline Leyser to Join UK Research and Innovation As New Chief Executive
Professor Dame Ottoline Leyser to Join UK Research and Innovation As New Chief Executive
Business Secretary Alok Sharma has announced that Professor Dame Ottoline Leyser DBE FRS will join UK Research and Innovation as its new Chief Executive. She will succeed Sir Mark Walport who announced in September last year that he would retire in 2020. Professor Leyser will start her new role on Monday June 29.
Survey Launches to Better Scope Open Infrastructure in Europe
Survey Launches to Better Scope Open Infrastructure in Europe
In collaboration with SPARC Europe, a survey to map Open Access (OA) and Open Science (OS) infrastructure across Europe was launched. The aim is to establish a core understanding of Europe's current field of Open resources and gain insight into their usage, durability, and adherence to core open principles and standards.
ELife Launches Service to Peer Review Preprints on BioRxiv
New initiative couples rapid release of new results with expert review.
Let's Say There's a Covid-19 Vaccine-Who Gets It First?
An immunization shot is still in development, but debate over who gets priority has already begun.
Facebook Will Pay $52 Million in Settlement with Moderators Who Developed PTSD on the Job
Facebook Will Pay $52 Million in Settlement with Moderators Who Developed PTSD on the Job
Current and former moderators will all be paid a minimum of $1,000. Selena Scola filed the case in California.
Women's Research Plummets During Lockdown - but Articles from Men Increase
Many female academics say juggling their career with coronavirus childcare is overwhelming.
How Academic Research Helps In The Fight Against The Coronavirus | Tapscape
Academic research is fundamental to learn more about the nature of the coronavirus.
The Science for Public Good Fund
If you are an early career scientist looking for ways to get involved with advocacy, or a faculty member who wants to engage your students in the role of science in democracy, the Science for Public Good Fund is for you.
The ERC: Funding Organisation and European Project
A review of some of the main characteristics that have made the ERC into the successful funding organisation that it is
Sure, the Velociraptors Are Still On the Loose, But That's No Reason Not to Reopen Jurassic Park
Sure, the Velociraptors Are Still On the Loose, But That's No Reason Not to Reopen Jurassic Park
Trump is shrugging off warnings by scientists that the easing restrictions taking place across the country could cause tens of thousands of death.
Purposes of Peer Review: A Qualitative Study of Stakeholder Expectations and Perceptions
Purposes of Peer Review: A Qualitative Study of Stakeholder Expectations and Perceptions
Authors, editors and publishers differ in their understanding of and the value they attach to the purposes of peer review.
Different worlds Confirmatory versus exploratory research
Explanation of the differences between confirmatory and exploratory research and the dangers of confusing the two concepts.
Beyond sex and gender analysis: an intersectional view of the COVID-19 pandemic outbreak and response
Spike Mutation Pipeline Reveals the Emergence of a More Transmissible Form of SARS-CoV-2
Spike Mutation Pipeline Reveals the Emergence of a More Transmissible Form of SARS-CoV-2
We have developed an analysis pipeline to facilitate real-time mutation tracking in SARS-CoV-2, focusing initially on the Spike (S) protein because it mediates infection of human cells and is the target of most vaccine strategies and antibody-based therapeutics.
×